Real-time Estimate
Other stock markets
|
5-day change | 1st Jan Change | ||
6.12 USD | -1.77% | -0.81% | +21.19% |
May. 15 | Wells Fargo Starts WAVE Life Sciences With Overweight Rating, $11 Price Target | MT |
May. 09 | Transcript : Wave Life Sciences Ltd., Q1 2024 Earnings Call, May 09, 2024 |
This article is reserved for members
Already a member?
Log InNot a member ?
Free registrationEPS Revisions
1st Jan change | Capi. | |
---|---|---|
+21.19% | 763M | |
+18.80% | 125B | |
+15.42% | 109B | |
-1.33% | 24.74B | |
+2.91% | 22.67B | |
-9.86% | 18.14B | |
-41.04% | 16.67B | |
-11.90% | 16.64B | |
+0.73% | 13.45B | |
+23.23% | 11.32B |
- Stock Market
- Equities
- WVE Stock
- News Wave Life Sciences Ltd.
- H.C. Wainwright Adjusts Price Target on WAVE Life Sciences to $15 From $8, Maintains Buy Rating